News

Filter

Current filters:

Respiratory and Pulmonary

1 to 9 of 666 results

Lupin links with Celon Pharma for generic Advair Diskus

Lupin links with Celon Pharma for generic Advair Diskus

18-02-2015

Indian drug major Lupin has entered into a definitive agreement with Polish drugmaker Celon Pharma to…

Advair DiskusCanadaCelon PharmaGenericsGlaxoSmithKlineLicensingLupinMarkets & MarketingMexicoRespiratory and PulmonaryUSA

AstraZeneca gets temporary injunction against Actavis over generic Pulmicort Respules

18-02-2015

Ireland-headquartered generics major Actavis yesterday confirmed that the US Court of Appeals for the…

ActavisAstraZenecaGenericsLegalPatentsPulmicort RespulesRespiratory and PulmonaryUSA

Actelion posts strong 2014 earnings growth, but sales shy of expectations

Actelion posts strong 2014 earnings growth, but sales shy of expectations

16-02-2015

Switzerland-based Actelion this morning reported financial results for full-year 2014, showing that sales…

ActelionBiotechnologyFinancialRespiratory and Pulmonary

Actavis launches generic Pulmicort Respules in USA

14-02-2015

Ireland-based generic drugs major Actavis has launched its generic version of Anglo-Swedish pharma major…

ActavisAstraZenecaGenericsLegalMarkets & MarketingPatentsPulmicort RespulesRespiratory and PulmonaryUSA

EMA’s PRAC recommends new measures to minimize known heart risks of hydroxyzine-containing medicines

13-02-2015

The European Medicines agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has completed a…

EuropeHydroxyzinePharmaceuticalRegulationRespiratory and PulmonaryUCB

Cumberland Pharma expands pipeline with Boxaban progress

11-02-2015

US drugmaker Cumberland Pharmaceuticals is expanding its pipeline with a new Phase II development program.

BoxabanCumberland PharmaceuticalsPharmaceuticalResearchRespiratory and Pulmonary

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

10-02-2015

Following a less than flattering financial performance in 2014, UK pharma major GlaxoSmithKline is realigning…

FinancialGlaxoSmithKlineOncologyPharmaceuticalRespiratory and Pulmonary

ALK Abello 2014 earnings rocket 76%

ALK Abello 2014 earnings rocket 76%

09-02-2015

Denmark-based allergy specialist ALK Abello posted financials this morning, saying it has achieved one…

ALK AbelloAustraliabioCSLCSL LtdFinancialLicensingNew ZealandPharmaceuticalRespiratory and PulmonarySouth Australia

1 to 9 of 666 results

COMPANY SPOTLIGHT

Menarini

Back to top